Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Alight Q4 2025 Earnings Call - New CEO Prioritizes Execution and AI After $803M Goodwill Hit, Suspends Dividend for Buybacks and Deleveraging
Rohit Verma, 30 working days into the job, framed Alight’s problems as an execution issue not a market one. Q4 and full-year 2025 showed soft renewals, margin pressure and a large non-cash goodwill im...
- New CEO Rohit Verma said Alight’s core issue is execution, not strategy, after 30 working days of client and employee meetings.
- Full-year 2025 revenue was $2.3 billion with adjusted EBITDA of $561 million and adjusted EBITDA margin of ~24.8%, down from $594 million and 25.2% in 2024.
- Q4 2025 revenue was $653 million; recurring revenue $607 million (down 1.6% YoY) and project revenue $46 million (down 27% YoY).
- +12 more takeaways
Madrigal Pharmaceuticals Q4 2025 Earnings Call - Rezdiffra posts near-$1B launch, company pivots to multi-drug MASH franchise
Madrigal closed its first full year of commercial sales with Rezdiffra at $958.4 million and Q4 revenue of $321.1 million, arguing the oral THR-beta agonist has established itself as the foundational ...
- Rezdiffra recorded Q4 2025 net sales of $321.1 million, bringing first full-year commercial sales to $958.4 million, a near-$1 billion launch in year one.
- Madrigal reports more than 36,250 patients on Rezdiffra at the end of Q4, up from over 29,500 at the end of Q3, indicating steady quarter-over-quarter patient adds.
- Management claims Rezdiffra is the foundational therapy in MASH, highlighting an oral, liver-directed profile that prescribers report is performing better than expected in the real world.
- +16 more takeaways
Gold Fields FY2025 Earnings Call - $3bn FCF, record payouts, but Ghana royalty risk looms
Gold Fields closed FY2025 with a cash surge and operational momentum, delivering roughly $3 billion of adjusted free cash flow and 2.44 million attributable ounces, up 18% year on year. Management use...
- Attributable production rose 18% to 2.44 million ounces in FY2025, driven by strong ramp-up at Salares Norte and higher throughput at several Australian assets.
- Adjusted free cash flow was just under $3.0 billion, up 391% year on year, with operations before tax generating about $5.5 billion.
- Headline earnings jumped 170% to $2.6 billion, helped by an average realized gold price near $3,500/oz for the period.
- +12 more takeaways
EPAM Q4 2025 Earnings Call - AI-native revenues scaling, targeting $600M in 2026
EPAM closed 2025 with a strong Q4 beat, driven by a clear strategic shift into AI-native engineering. Q4 revenue was $1.4 billion (up 12.8% reported, 5.6% organic constant currency), with AI-native re...
- Q4 2025 revenue $1.4 billion, up 12.8% year-over-year on a reported basis and +5.6% organic constant currency.
- Full-year 2025 revenue $5.46 billion, +15.4% reported and +4.9% organic constant currency.
- EPAM reported more than $105 million of pure AI-native revenue in Q4 and expects to scale AI-native revenues to in excess of $600 million in 2026.
- +16 more takeaways
Insmed Q4 2025 Earnings Call - BRINSUPRI on track for at least $1B in 2026 after a blockbuster early launch
Insmed spent 2025 turning a clinical win into a commercial one. BRINSUPRI ripped through its first full quarter with $144.6 million in net revenue, prompting management to guide at least $1 billion fo...
- BRINSUPRI posted $144.6 million in net revenue in its first full quarter and management now guides BRINSUPRI revenue of at least $1 billion in 2026.
- Insmed expects total company revenue in 2026 to more than double 2025 levels, driven by BRINSUPRI plus continued ARIKAYCE growth.
- ARIKAYCE had a strong 2025, with Japan producing 40% year-over-year growth and Europe growing faster from a smaller base; ENCORE Phase III readout expected March or April 2026.
- +12 more takeaways
Wayfair Q4 2025 Earnings Call - Share capture driving profitable growth via Rewards, stores, and tech
Wayfair closed 2025 with accelerating, profitable share gains. Revenue grew 7.8% year‑over‑year excluding Germany, and Q4 delivered $224 million of adjusted EBITDA as the company converted top‑line mo...
- Top line: Net revenue grew 6.9% reported and 7.8% year‑over‑year excluding Germany in Q4 2025; U.S. up over 7%, international near 4%.
- Profitability: Q4 adjusted EBITDA was $224 million, a 6.7% margin, more than double Q4 2024; full year 2025 adjusted EBITDA rose to $743 million, up over 60% year‑over‑year.
- Contribution economics: Q4 adjusted gross margin was 30.3%, contribution margin 15.3% after customer service/merchant fees (~3.7%) and advertising (11.4%).
- +12 more takeaways
Materialise Fourth Quarter 2025 Earnings Call - Medical outperformance lifts margins while manufacturing lags
Materialise closed Q4 2025 with a clear polarization: medical skyrocketed, software stabilized through a cloud transition, and manufacturing remained a drag. Consolidated Q4 revenue rose 6.8% to EUR 7...
- Dual listing completed on Euronext Brussels on November 20, 2025, complementing the Nasdaq listing and increasing European investor access and operational flexibility.
- Board approved a share buyback program of up to EUR 30 million; program started January 26, 2026 and 187,500 shares were repurchased to date for just under $1 million.
- Q4 consolidated revenue was EUR 70.2 million, up 6.8% year-on-year; full year 2025 revenue was EUR 268 million, essentially flat vs 2024.
- +17 more takeaways
Gladstone Commercial Corporation Q4 2025 Earnings Call - Industrial Pivot Accelerates with 69% Industrial Share and $600M Credit Facility
Gladstone Commercial used 2025 to lean into industrial real estate, buying $206 million of industrial assets and lifting industrial annualized straight line rent to 69% of the portfolio. Occupancy sit...
- Company acquired $206 million of industrial assets in 2025 across 10 facilities, totaling 1.6 million square feet, with a weighted average cap rate of 8.88% and a weighted average lease term at closing of 15.9 years.
- Industrial concentration rose to 69% of annualized straight line rent as of December 31, 2025, up from 63% a year earlier, and management is targeting at least 70% industrial mix.
- Portfolio occupancy is 99.1%, with 100% cash-based rent collection in the period, and average remaining lease term across the portfolio is 7.3 years.
- +13 more takeaways
Walmart Q4 FY2026 Earnings Call - E-commerce, AI and advertising drive faster profit growth, ad plus membership now ~1/3 of operating income
Walmart closed FY26 with steady top-line expansion and accelerating profit momentum. Consolidated revenue rose 4.9% in constant currency, e-commerce grew 24% and adjusted operating income climbed 10.5...
- Consolidated revenue rose 4.9% in constant currency in Q4, with global e-commerce up 24% year-over-year.
- Adjusted operating income grew 10.5% in constant currency, outpacing sales growth in all three segments for the quarter.
- Walmart U.S. comp sales were up 4.6% in Q4, and U.S. e-commerce grew 27% for the quarter.
- +15 more takeaways
Americold Realty Trust Fourth Quarter 2025 Earnings Call - Deleveraging Push to Restore Investment Grade, AFFO Guide $1.20-$1.30
Americold closed 2025 with modest operational improvements and a clear, urgent priority to repair its balance sheet. Q4 AFFO came in at $0.38, full-year AFFO was $1.43, and economic occupancy improved...
- Q4 AFFO per share $0.38, slightly ahead of expectations, full-year 2025 AFFO $1.43 in line with guidance.
- 2026 AFFO guidance $1.20 to $1.30 per share, management anticipates H2 seasonality with Q1 as the trough.
- End-of-Q4 leverage 6.8x, company targeting material deleveraging to regain investment-grade status; exploring joint ventures or sale of non-strategic assets, more detail expected in H1 2026.
- +12 more takeaways